(1)
Dschietzig, T. B.; Salama, G. Relaxin-2 for Heart Failure With Preserved Ejection Fraction: A Comment on the Termination of a Phase-II Trial Investigating the Relaxin-2 Analogue, LY3540378. Global Cardiol 2024, 2.